Information Journal Paper
APA:
Copy. (2020). TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. JOURNAL OF MICROBIOLOGY, IMMUNOLOGY AND INFECTION, -(-), 0-0. SID. https://sid.ir/paper/744579/en
Vancouver:
Copy. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. JOURNAL OF MICROBIOLOGY, IMMUNOLOGY AND INFECTION[Internet]. 2020;-(-):0-0. Available from: https://sid.ir/paper/744579/en
IEEE:
Copy, “TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib,” JOURNAL OF MICROBIOLOGY, IMMUNOLOGY AND INFECTION, vol. -, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/744579/en